Bunnage Mark E. Insider Trades

Insider Trading History

Track insider trading activity for Bunnage Mark E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $3.41M 7,284 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$15k 33 shares
$453.45
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $3.41M 7,284 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$302k 620 shares
$486.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $3.7M 7,904 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$282k 582 shares
$485.11
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $3.97M 8,486 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$560k 1,182 shares
$473.68
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $4.53M 9,668 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.19M 2,437 shares
$489.46
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $6.19M 13,215 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 2,584 shares
$477.40
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $5.67M 12,105 shares
Last Trade
Feb 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$537k 1,110 shares
$483.75
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $4.98M 10,631 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.11M 2,283 shares
$487.76
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $6.05M 12,914 shares
Last Trade
Feb 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$931k 2,021 shares
$460.43
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Scientific Officer
Holding Value $6.99M 14,935 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$528k 1,127 shares
$468.41
$468.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up